Historical record - last NADAC effective date: 5/20/2015
Product Information
ADT ROBITUSSIN PEAK CLD M-S LQ is a brand product labeled by Haleon US Holdings LLC, priced at $0.0368 per ML under NDC 00031874214. Its NADAC has been published 97 times since Nov 28, 2013.
ADT ROBITUSSIN PEAK CLD M-S LQ
dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochlorideStrength
10; 100; 5 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Haleon US Holdings LLCNDC
00031874214
Classification
Brand
Dosage Form
LIQUID
Route
ORAL
Effective Date
5/20/2015
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/12/2011
Pharmacological Classes
Price Statistics
The NADAC for ADT ROBITUSSIN PEAK CLD M-S LQ has been published 97 times since Nov 28, 2013, and over the history we have for it it has risen 2.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0368 per ML |
|---|---|
| All-time high | $0.0385 (Apr 15, 2015) |
| All-time low | $0.0349 (Sep 17, 2014) |
| Median price | $0.0368 |
| Average price | $0.0365 |
| Largest weekly change | +6.4% (Nov 19, 2014) |
| Weeks tracked | 97 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+2.4%
Last surveyed Sep 30, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Haleon US Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ADT ROBITUSSIN PEAK CLD M-S LQ?
The current National Average Drug Acquisition Cost (NADAC) for ADT ROBITUSSIN PEAK CLD M-S LQ, manufactured by Haleon US Holdings LLC, is $0.0368 per ML (NDC 00031874214), effective Sep 30, 2015.
How has the price of ADT ROBITUSSIN PEAK CLD M-S LQ changed over time?
Over the history we have for it, the NADAC for ADT ROBITUSSIN PEAK CLD M-S LQ has risen 2.4%. It has been tracked across 97 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ADT ROBITUSSIN PEAK CLD M-S LQ?
Since Nov 28, 2013, the NADAC for ADT ROBITUSSIN PEAK CLD M-S LQ has ranged from a low of $0.0349 (Sep 17, 2014) to a high of $0.0385 (Apr 15, 2015), with a median of $0.0368 per ML.
Are there cheaper alternatives to ADT ROBITUSSIN PEAK CLD M-S LQ?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ADT ROBITUSSIN PEAK CLD M-S LQ, is $0.0284 per ML — about 23% below ADT ROBITUSSIN PEAK CLD M-S LQ.
Who manufactures ADT ROBITUSSIN PEAK CLD M-S LQ?
ADT ROBITUSSIN PEAK CLD M-S LQ (NDC 00031874214) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.